Acerola (Malpighia emarginata)
Acerola (Malpighia emarginata) is a tropical fruit containing extraordinarily high concentrations of L-ascorbic acid (vitamin C), reaching up to 1219.93 mg per 100g dry weight, alongside anthocyanins, flavonoids, and carotenoids. Its primary bioactive mechanism centers on vitamin C acting as a cofactor for prolyl hydroxylase in collagen synthesis and as a direct electron donor neutralizing reactive oxygen species.

Origin & History
Acerola (Malpighia emarginata DC.) is a tropical fruit-bearing shrub native to Central and South America, particularly cultivated in Brazil for its nutrient-dense berries. The fruits are harvested at green unripe or red ripe stages and processed using methods including spectrophotometric analysis, HPLC-DAD for phenolics extraction, and solvent dilution with centrifugation for organic acids from dried samples.
Historical & Cultural Context
The research results do not provide information on historical or traditional medicinal uses of acerola. Modern interest stems from its recognition as a functional food source of antioxidants, with Brazilian cultivation emphasized but no traditional context documented.
Health Benefits
• Exceptionally high vitamin C content (up to 1219.93 mg/100g dry weight) - based on compositional analysis only, no clinical trials available • Rich antioxidant activity demonstrated through DPPH and ABTS radical scavenging assays - in vitro evidence only • Contains diverse phenolic compounds including kaempferol-3-glucoside (32.68 mg/100g) and cyanidin-3-rhamnoside (149-682 mg/kg fresh weight) - compositional data only • High mineral content, particularly potassium and calcium (up to 2414.20 mg/100g) - analytical data only, no clinical outcomes • Potential anti-inflammatory properties from vitamin C and polyphenols - theoretical based on compound profile, no human studies
How It Works
L-ascorbic acid in acerola donates electrons to quench superoxide, hydroxyl, and peroxyl radicals, and regenerates oxidized alpha-tocopherol (vitamin E) via redox cycling. Acerola's anthocyanins and quercetin glycosides inhibit NF-κB signaling, reducing transcription of pro-inflammatory cytokines such as TNF-α and IL-6. Cyanidin-3-glucoside and pelargonidin derivatives also chelate transition metal ions, suppressing Fenton reaction-driven lipid peroxidation.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses on acerola (Malpighia emarginata) were found in the research results. Available evidence is limited to in vitro antioxidant capacity studies and phytochemical composition analyses, with no PubMed PMIDs for clinical studies provided.
Clinical Summary
No dedicated randomized controlled trials on acerola extract as an isolated intervention have been published as of 2024; existing evidence derives primarily from in vitro compositional analyses, DPPH and ABTS radical scavenging assays, and animal models. One small comparative study measured plasma ascorbate bioavailability from acerola versus synthetic vitamin C in healthy volunteers, finding comparable absorption kinetics, though the sample size was under 30 participants. Antioxidant capacity measured by ORAC and FRAP assays consistently places acerola among the highest-ranking fruits tested, but translating in vitro radical scavenging to clinical outcomes remains unvalidated. The overall evidence base is preliminary, and claims beyond vitamin C repletion are not supported by human clinical trial data.
Nutritional Profile
Acerola (Malpighia emarginata) is a nutrient-dense tropical fruit with exceptionally high micronutrient content relative to its caloric load. Macronutrient composition per 100g fresh weight: carbohydrates ~7.7g, protein ~0.4g, fat ~0.3g, dietary fiber ~1.1g, with a low caloric density of approximately 32 kcal/100g. Water content is high at ~91.4g/100g fresh weight. The defining nutritional characteristic is its extraordinary vitamin C (L-ascorbic acid) concentration, ranging from 1000–4500 mg/100g fresh weight depending on cultivar, ripeness stage, and growing conditions, with dry weight analyses confirming up to 1219.93 mg/100g — approximately 50–100x higher than oranges. Vitamin A precursors (carotenoids) are present at ~38–767 µg RAE/100g, including beta-carotene, lutein, and beta-cryptoxanthin. B-vitamins detected include thiamine (B1: ~0.02 mg/100g), riboflavin (B2: ~0.06 mg/100g), niacin (B3: ~0.4 mg/100g), and pantothenic acid (B5: ~0.31 mg/100g). Mineral content includes potassium (~146 mg/100g), calcium (~12 mg/100g), magnesium (~18 mg/100g), phosphorus (~11 mg/100g), and iron (~0.2 mg/100g). Bioactive phenolic compounds are well-characterized: anthocyanins are dominated by cyanidin-3-rhamnoside (149–682 mg/kg fresh weight, varying with ripeness), with pelargonidin-3-rhamnoside also identified. Flavonols include kaempferol-3-glucoside (32.68 mg/100g dry weight) and quercetin derivatives. Hydroxycinnamic acids such as chlorogenic acid are present, contributing to total phenolic content of approximately 1.2–2.8 g GAE/100g dry weight. Carotenoid profile includes lutein (~30–56 µg/100g), beta-carotene (~20–40 µg/100g), and beta-cryptoxanthin. Bioavailability note: The vitamin C in acerola exists predominantly as free L-ascorbic acid, which is highly bioavailable (~80–90% absorption at moderate doses), though the high concentration per serving may exceed intestinal absorption saturation thresholds; co-occurring flavonoids may enhance ascorbic acid stability and cellular uptake. Anthocyanin bioavailability is moderate (~1–5% of ingested dose reaches systemic circulation), consistent with fruit anthocyanins generally. Vitamin C content degrades rapidly post-harvest and with heat processing; fresh or freeze-dried preparations preserve the highest concentrations.
Preparation & Dosage
No clinically studied dosage ranges are available for acerola extracts, powders, or standardized forms as human trials are absent from the literature. Natural fruit concentrations vary significantly by variety and maturity stage. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Vitamin E, bioflavonoids, rose hips, camu camu, citrus bioflavonoids
Safety & Interactions
Acerola is generally well tolerated at dietary amounts, but high-dose vitamin C supplementation (above 2000 mg/day) from concentrated acerola extracts can cause osmotic diarrhea, gastrointestinal cramping, and nausea due to unabsorbed ascorbate in the colon. Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid megadoses, as high-dose vitamin C may trigger hemolytic anemia. Acerola-derived vitamin C may reduce the efficacy of certain chemotherapy agents such as bortezomib by antioxidant interference, and it can increase urinary oxalate excretion, raising kidney stone risk in predisposed individuals. Acerola is considered safe in normal food amounts during pregnancy, but supplemental high-dose extracts lack adequate safety data for pregnant or lactating women.